Title
Supreme Court
Implementing Rules of Comprehensive Dangerous Drugs Act
Law
Ddb Implementing Rules And Regulations (irr) Of Republic Act No. 9165, August 30, 2002
Decision Date
Aug 30, 2002
The Implementing Rules and Regulations (IRR) of Republic Act No. 9165, also known as the Comprehensive Dangerous Drugs Act of 2002, covers the establishment and funding of drug rehabilitation centers, jurisdiction over drug cases, responsibility and liability of law enforcement agencies and government officials, reclassification of drugs, and the creation of a Congressional Oversight Committee on Dangerous Drugs (COCDD).

Law Summary

Fundamental Definitions

  • Defines key terms such as Accreditation, Dangerous Drugs, Drug Syndicate, Manufacture, Sale, Possession, Use, and others essential for the Act's implementation.
  • Includes definitions of legal and illegal acts related to drugs.
  • Describes roles such as Financier, Protector/Coddler, Drug Dependent.

Unlawful Acts and Corresponding Penalties

  • Importation, sale, manufacture, maintenance of drug dens, possession, and use of dangerous drugs and chemicals are penalized with imprisonment and fines.
  • Aggravated penalties for offenses involving minors, use of diplomatic facilities, commission within 100 meters of schools.
  • Specific penalties for employees of drug dens and visitors aware of illegal activities.
  • Illegal chemical diversion and manufacture of drug paraphernalia punishable.
  • Planting evidence results in death penalty.
  • Public officers involved in drug offenses face life imprisonment, fines, and disqualification from office.

Confiscation and Disposition of Seized Items

  • Proceeds, properties, and instruments related to drug offenses are confiscated and forfeited to the government.
  • PDEA is tasked with custody and orderly destruction of seized drugs, equipment, and chemicals.
  • Detailed procedures for inventory, testing, and destruction of confiscated items provided.

Drug Testing Regulations

  • Drug testing mandatory for various categories including driver and firearm license applicants, students, employees, military and law enforcement personnel, criminal suspects, and public office candidates.
  • DOH accredits testing centers and physicians conducting assessments.
  • False drug test results subject to severe penalties.

Participation of Families, Schools, and Communities

  • Families responsible for prevention and education on drug abuse.
  • Schools integrate drug prevention education into curricula at all levels.
  • School officials empowered to apprehend drug offenders within school premises.
  • Student councils to implement anti-drug programs.
  • Special Drug Education Centers to be established for out-of-school youth.

Workplace Drug-Free Policies

  • DOLE to develop workplace drug prevention programs for companies with ten or more employees.
  • Programs include drug testing, employee assistance, and advocacy.
  • Labor organizations involved in promoting drug-free workplaces within collective bargaining agreements.

Local Government Units' Role

  • Funds appropriated towards enforcement, education, rehabilitation, and abatement of drug-related nuisances.
  • Procedures for declaring places used for illegal drug activities as public nuisances and for their abatement.

Drug Dependent Treatment and Rehabilitation Programs

  • Voluntary and compulsory submission programs for treatment and rehabilitation.
  • Courts involved in handling applications and commitments.
  • Conditions for exemption from criminal liability for rehabilitated dependents.
  • Supervision and follow-up treatment mandated post-release.
  • Confidentiality of rehabilitation records ensured.
  • Provisions for escape and recommitment.
  • Cost-sharing guidelines for rehabilitation treatment developed.

Dangerous Drugs Board (DDB) and Philippine Drug Enforcement Agency (PDEA)

  • DDB is the policy-making body; PDEA is the implementing agency.
  • Detailed composition, powers, duties, and organizational structure outlined.
  • PDEA tasked with enforcement, investigation, prosecution support, and international coordination.
  • Establishment of PDEA Academy for specialized training.
  • Integration of existing drug enforcement units into PDEA under specified transition periods.

Appropriations, Fund Management, and Reporting

  • Funding sources include government appropriations, fines, donations, PCSO and PAGCOR shares.
  • Special accounts established with strict guidelines on fund use.
  • Annual reporting by DDB Chairperson to the President and Congress.
  • COA auditing of all financial accounts and expenses.

Jurisdiction and Prosecution of Drug Cases

  • Special courts designated to exclusively try drug-related offenses.
  • Strict timelines for preliminary investigations, trial, and decisions.
  • Mandatory appearance of law enforcement and government witnesses with penalties for non-compliance.
  • Punishment for delay or bungling in prosecution.

Reclassification of Drugs

  • DDB empowered to reclassify, add, or remove drugs from the dangerous drugs list.
  • Procedures involve investigations, public hearings, and consideration of scientific and public health factors.
  • Effects of reclassification on pending prosecutions explained.

Congressional Oversight Committee on Dangerous Drugs (COCDD)

  • Composed of members from both Houses of Congress.
  • Functions include monitoring law implementation, transparency, budget approval, and reporting.
  • Powers to summon and subpoena.
  • Funded initially by Senate appropriations with ongoing funding in General Appropriations Act.
  • Mandated existence for ten years, extendable.

Final Provisions

  • Applicability rules of the Revised Penal Code clarified.
  • Separability clause for invalid provisions.
  • Repeal of inconsistent issuances.
  • Rules for IRR implementation and effectivity specified.

Analyze Cases Smarter, Faster
Jur is a legal research platform serving the Philippines with case digests and jurisprudence resources. AI digests are study aids only—use responsibly.